CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance & Accounting sold 6,607 shares at $14.00 ($92,498)
- 4 Open-market sale See Remarks sold 10,000 shares at $12.08 ($120,826)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Scientific Officer acquired 6,350 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 2,951 shares at $20.00 ($59,020)
- 4 Open-market sale See Remarks sold 2,500 shares at $20.00 ($50,000)
- 4 Open-market sale SVP Clinical Development sold 1,071 shares at $18.30 ($19,599)
- 4 Open-market sale Chief Scientific Officer sold 141 shares at $20.00 ($2,820)
- 4 Open-market sale SVP Clinical Development sold 1,459 shares at $22.00 ($32,098)
- 4 Open-market sale See Remarks sold 2,500 shares at $20.80 ($51,992)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 12 · 221 filings